Creating long-lasting treatments for tuberculosis
Development of sustained release/long acting products for TB
This study is looking at new ways to create long-lasting medications for people with latent tuberculosis infection (LTBI), especially those who also have HIV, to make it easier for them to stick to their treatment and help prevent TB from coming back.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10989407 on NIH RePORTER |
What this research studies
This research focuses on developing sustained release and long-acting formulations for treating latent tuberculosis infection (LTBI), particularly in individuals co-infected with HIV. The approach aims to improve adherence to treatment regimens, which is crucial for preventing the reactivation of TB and the development of drug resistance. By creating formulations that allow for less frequent dosing, the study seeks to enhance the effectiveness of LTBI treatments while minimizing drug interactions with HIV therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with latent TB infection, particularly those who are also HIV positive.
Not a fit: Patients who do not have latent TB infection or are not at risk for TB reactivation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and easier-to-follow treatment options for patients with latent TB, especially those living with HIV.
How similar studies have performed: Other research has shown promise in developing long-acting formulations for various conditions, suggesting potential success for this approach in treating LTBI.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Garcia-Martinez, J. Victor — University of Alabama at Birmingham
- Study coordinator: Garcia-Martinez, J. Victor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.